Diabetes News and Research

Latest Diabetes News and Research

Six research project grants aimed at improving human health awarded

Six research project grant awards totaling $5.1 million will be made to Washington life sciences organizations and their partners, the state’s Life Sciences Discovery Fund announced today.

16 Sep 2009

Medicare Advantage's preventive health care strategy keeps seniors out of the hospital

Seniors in Medicare Advantage spent fewer days in a hospital, were subject to fewer hospital re-admissions, and were less likely to have "potentially avoidable" admissions, for common conditions ranging from uncontrolled diabetes to dehydration, according to a new analysis of publicly available AHRQ data released today by America's Health Insurance Plans (AHIP).

16 Sep 2009

Acute kidney injury multiplies the risk of future kidney complications

Patients who sustain injury to their kidneys and require in-hospital dialysis are three times more likely to need long-term dialysis later in life compared to those without a history of this condition, says a new study from St. Michael's Hospital.

16 Sep 2009

Transcendental Meditation aids students diagnosed with ADHD

A panel of physicians and scientists will report on the benefits of a simple meditation practice for aiding students diagnosed with ADHD during a national medical webinar, which will be hosted by the David Lynch Foundation on Wednesday, September 30, 12 noon (ET).

16 Sep 2009

GENova Biotherapeutics signs LOI with Prime BioResearch

GENova Biotherapeutics Inc. ("GENova") today announced it has signed an LOI with Prime BioResearch, Ltd. ("Prime BioResearch"), another drug acquisition company in the areas of drug development and distribution a business case that will save GENova millions every year in drug development and at the same time more than double GENova's distribution network enabling GENova to potentially exceed its own expectations of reaching 100m+ in revenue in year.

16 Sep 2009

Study reveals ineffectiveness of insulin and metformin against inflammatory biomarkers

In patients with recent onset type-2 diabetes, treatment with insulin or the diabetes drug metformin did not reduce inflammatory biomarkers, such as high-sensitivity C-reactive protein, although the treatment did improve glucose control, according to a study in the September 16 issue of JAMA.

16 Sep 2009

GENova Biotherapeutics and Prime BioResearch sign collaboration agreement

GENova Biotherapeutics Inc. ("GENova") today announced that it has signed a collaboration agreement with Prime BioResearch, Ltd. ("Prime BioResearch") the agreement is focused on how personalized medicine can be applied to cure cancer.

16 Sep 2009

Aviva Select series of Disease Management and Wellness programs launched

Avivia Health announces Avivia Select, a new series of affordable Disease Management and Wellness programs specifically designed to help companies provide important new benefits to their employees. Avivia Health is the only national provider of Disease Management and Wellness Solutions based on 60 years of evidence-based care by parent organization Kaiser Permanente.

16 Sep 2009

NCI-funded SPORE grant aims to improve kidney cancer treatment

The National Cancer Institute (NCI) has awarded Beth Israel Deaconess Medical Center (BIDMC) an $11.5 million, five-year SPORE grant to focus on cancers of the kidney. Michael Atkins, MD, Deputy Director of BIDMC's Division of Hematology/Oncology, will oversee the grant, which involves collaborations with Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital via the Dana-Farber/Harvard Cancer Center.

16 Sep 2009

Researchers analyze how genome influences human health

Two recent studies by Dartmouth researchers use individual genetic data to reveal the powers and limits of our current understanding of how the genome influences human health and what genes can reveal about the ancestry of the people of New Hampshire.

15 Sep 2009

The Miriam Hospital researchers study brain activity patterns

A difference in brain activity patterns may explain why some people are able to maintain a significant weight loss while others regain the weight, according to a new study by researchers with The Miriam Hospital.

15 Sep 2009

Alvine Pharmaceuticals raises funds for Phase 2a clinical trial of its lead compound ALV003

Alvine Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on developing and commercializing therapeutics for autoimmune/gastrointestinal diseases, today announced the closing of a $21.5 million extension of its Series A financing.

15 Sep 2009

American Lung Association urges families to get immunized against seasonal influenza

The American Lung Association is intensifying its seasonal influenza public education initiative to urge families to get vaccinated as soon as possible. The Faces of Influenza campaign aims to ensure Americans get immunized against seasonal influenza, which each year causes an estimated 36,000 deaths and over 226,000 hospitalizations from the virus and its related complications.

15 Sep 2009

NMQF launches the P.A.D. Atlas database that maps peripheral arterial disease prevalence by zip code

The National Minority Quality Forum (NMQF), one of the nation's leading voices in the health disparities discussion, is launching the P.A.D. Atlas, a database that maps by zip code peripheral arterial disease (P.A.D.) prevalence down to the street level, with the P.A.D. Coalition and support from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.

15 Sep 2009

RAPS honors award recipients for contributions to healthcare product regulatory profession

The Regulatory Affairs Professionals Society (RAPS) today honored the recipients of its prestigious awards for outstanding contributions to the healthcare product regulatory profession. RAPS' Leonard Stauffer Award for mentoring and furthering regulatory professional education was given to independent consultant Nanci Dexter.

15 Sep 2009

CPEX Pharmaceuticals to discuss the clinical aspects of nasal insulin therapy

CPEX Pharmaceuticals, Inc. (“CPEX”) today announced that it will participate in the Ninth Annual Diabetes Technology Meeting to be held November 5–7, 2009, at the Hyatt Regency Airport in San Francisco, California. Dr. Lance Berman, Senior Vice President and Chief Medical Officer, is scheduled to present an oral presentation titled “The Technology and Clinical Aspects of Nasal Insulin Therapy” at 9:30 a.m. PST on Saturday, November 7, 2009.

15 Sep 2009

NYSDOH blocks U.S.-Egypt study of ozone-based medical therapies for diabetic skin ulcers

A study exploring the healing of diabetic skin ulcers using topical oxygen/ozone gas mixtures could not proceed to completion and was now abandoned, according to Ozonics International, LLC, a veteran-owned biotechnology company engaged in the research and development of ozone-based medical therapies.

15 Sep 2009

Lexicon initiates Phase 2 clinical trial of LX4211 in patients with type 2 diabetes mellitus

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained favorable results from recently completed Phase 1 studies of LX4211 and announced today that it has initiated a Phase 2 clinical trial of the drug candidate in patients with type 2 diabetes mellitus.

15 Sep 2009

New program educates parents on fun, healthy mealtime ideas

How did the simple act of eating become so difficult? Between basic nutrition, the obesity epidemic, allergies, food recalls, and chemical contaminants, feeding children a healthy diet has never been so complicated. Eat Healthy, a new program from Healthy Child Healthy World, makes it easy.

15 Sep 2009

National Community Pharmacists Association calls for suspension of the DMEPOS accreditation requirement

The National Community Pharmacists Association (NCPA), has written a letter to Charlene Frizzera, Centers for Medicare and Medicaid Services (CMS) Acting Administrator, urging a suspension of the Medicare Part B Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) accreditation requirement scheduled for October 1.

15 Sep 2009

Diabetes News and Research

Latest Diabetes News and Research

Six research project grants aimed at improving human health awarded

Medicare Advantage's preventive health care strategy keeps seniors out of the hospital

Acute kidney injury multiplies the risk of future kidney complications

Transcendental Meditation aids students diagnosed with ADHD

GENova Biotherapeutics signs LOI with Prime BioResearch

Study reveals ineffectiveness of insulin and metformin against inflammatory biomarkers

GENova Biotherapeutics and Prime BioResearch sign collaboration agreement

Aviva Select series of Disease Management and Wellness programs launched

NCI-funded SPORE grant aims to improve kidney cancer treatment

Researchers analyze how genome influences human health

The Miriam Hospital researchers study brain activity patterns

Alvine Pharmaceuticals raises funds for Phase 2a clinical trial of its lead compound ALV003

American Lung Association urges families to get immunized against seasonal influenza

NMQF launches the P.A.D. Atlas database that maps peripheral arterial disease prevalence by zip code

RAPS honors award recipients for contributions to healthcare product regulatory profession

CPEX Pharmaceuticals to discuss the clinical aspects of nasal insulin therapy

NYSDOH blocks U.S.-Egypt study of ozone-based medical therapies for diabetic skin ulcers

Lexicon initiates Phase 2 clinical trial of LX4211 in patients with type 2 diabetes mellitus

New program educates parents on fun, healthy mealtime ideas

National Community Pharmacists Association calls for suspension of the DMEPOS accreditation requirement

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Diabetes News and Research

Latest Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in